Daily News Podcast

Novel formulation for childhood ADHD

Publish date: November 20, 2018

 

A novel formulation of methylphenidate could provide morning relief to pediatric patients with attention-deficit hyperactivity disorder. Also today, CARE MD protocol could help treat somatic disorders, children with poor cardiorespiratory fitness have a higher risk of type 2 diabetes, and ganglion stimulation boosts cerebral blood flow and improves stroke outcomes.
Amazon Alexa
Apple Podcasts
Google Podcasts

Recommended Reading

Hypertension and CVD risk for young adults
MDedge Rheumatology
Biomarkers and concussions
MDedge Rheumatology
Some statins worse than others for musculoskeletal adverse event onset time
MDedge Rheumatology
Samuel Shem: Part II
MDedge Rheumatology
Trump rule and ACA contraception
MDedge Rheumatology
Heart failure and sacubiril/valsartan
MDedge Rheumatology
Vitamin D, fish out, and primary prevention
MDedge Rheumatology
USPSTF: screen for ‘unhealthy’ alcohol use
MDedge Rheumatology
Obesity curbs decades of CVD progress
MDedge Rheumatology
Physical fitness guidelines from HHS
MDedge Rheumatology